Navigation Links
Proteomic High Voltage Power Supplies

ProductsProteomic High Voltage Power Supplies
Company ThermoFisher Scientific
Item Proteomic High Voltage Power Supplies
Features 
  • Versatile for a wide range of applications: From simple techniques such as submarine electrophoresis and SDS-PAGE, to DNA Sequencing and Multiple Step IEF, the Series 90 Programmable Power Supplies will support virtually any application. All models operate in constant voltage, current or power operating modes with automatic crossover between modes.
  • Programming designed for maximum ease-of-use: These programmable power supplies should be simple and convenient. They offer a large LCD screen display as well as a LED readout of voltage for easy visibility. This product also offers a smart key approach to programming that makes programming simple for the user and allows the user to retain their information eve when the unit is turned off.
  • Sophisticated safety features: All programmable power supplies feature a number of built-in circuits to protect and alert the user to potentially unsafe operating conditions. Each is also equipped with an advanced ground leakage detection system to protect users.
Description The PRO6000 power supply is the latest edition to Thermo's power supply product offering. It sets new standards in proteomic and genomic electrophoresis. This product has unique features dedicated to proteomic applications such as microAmp detector, display and linear voltage.
Info ThermoFisher Scientific
Web site: http://www.thermo.com
Web site: http://www.thermofisher.com/global/en/home.asp

Related medicine products :

1. Voltage-Gated Calcium Channel (VGCC) Autoantibody RIA
2. High Voltage Programmable Power Supplies
3. High Voltage Non-Programmable Power Supplies
4. 250-90 Low Voltage Power Supply
5. 105 Low Voltage Power Supply
6. Voltage-Gated Calcium Channel (VGCC) Antibody
7. PowerLab/4SP
8. PowerLab/8SP
9. PowerLab/16SP
10. PowerLab/4ST
11. PowerLab 2/25
...reatly improved with Volk's exclusive Double Asphe... precise and focused laser beam placement at the c...ng and laser treatment of the posterior capsule. T...indow for optimal laser beam transmission and imag...
...offers extremely high resolution treatment capabil...exceptionally wide 78° field of view. This len...f the optic nerve head and macula. Excellent stere...edesigned to reduce weight and size. High magnific...
...ent for critically evaluating and treating subreti...generation, retinal vascular occlusions, diabetic ...and other retinal conditions. It is ideal for foca...cellent magnification combined with a good field o...
...ns has grown in popularity since its introduction ...ens. Its sleek 28.6mm diameter housing provides a ...ses for peripheral retinal viewing, reflection dis... for small pupil fundus examination and as a gener...
Medicine Products:
(Date:10/6/2008)...t. 6 /PRNewswire/ -- Developed in collaboration wi...ades, CA is introducing,Revolutionary Breast Surfa...c Surgery office of Dr. Steve Laverson this week i...he first of its kind, and is based on,breakthrough...with,innovative proprietary software. The XS-300(T...
(Date:10/6/2008)...ct. 6 /PRNewswire/ -- The organizers of Informex a...e on Global Sourcing for the,Pharmaceutical Indust...inceton Marriott in New Jersey USA., The conferen... the,Global Sourcing Council, and boasts an unpara...e likes of Johnson & Johnson, Bristol Myers Squibb...
(Date:10/6/2008)... LegalView recently posted detailed inform...he potentially serious side effects caused by the ... the drug,s potential side effects are the develop... for young adult and child patients. , ...- LegalView, the number one resource for everythin...
(Date:10/6/2008)... Hospital Ship Serving in West Africa Rece...Garden Valley, Texas October 6, 2008 -- www.seamob...l provider of communications services to remote lo...s to the FoxNews channel via satellite to Mercy Sh...ica Mercy. The Africa Mercy is the world,s larges...
Breaking Medicine News(10 mins):Health News:Plan Your Breasts in 3-D 2Health News:Global Sourcing Strategies for the Pharmaceutical Industry 10th - 11th November, Marriott Princeton, New Jersey USA 2Health News:LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis 2Health News:LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis 3Health News:Seamobile Provides Foxnews To Mercy Ships 2Health News:Seamobile Provides Foxnews To Mercy Ships 3
... commonly women suffer from osteoporosis after men...have been found to protect women from osteoporosis...the menopause and involves a reduction in bone den...e fractures. Doctors at the University of Atlanta,...
...rding to a recent study, a combined scan identifie...at may signify danger of heart attack in the futur...for heart disease. The build up of plaque - athero...s occur.// The plaque narrows the arteries, and ma...
...rding to recent study, a simple imaging test may i...s a potentially fatal heart condition. Researchers...ful way to diagnose hypertrophic cardiomyopathy ea...myopathy (HCM) causes thickening of the left ventr...
...d on a research on aborigines in solitary parts of...mass index might be lower than previously thought....ng your mass in kilograms by your height in metres...nsidered to be the healthy range, while 25 to 30 i...
Other Medicine News:
(Date:10/6/2008)...ented at ACG Annual Scientific Conference -, ORLA...euticals,(formerly Microbia) today announced prese... delineating the role that cyclic guanosine,monoph...n. These studies,demonstrate that cGMP inhibits in... hyperalgesia and desensitizes colonic afferent ne...
(Date:10/6/2008)...e 3b Studies with Durezol Dosed Prior to Surgery, ...eutics, Inc., a,privately held ophthalmic-focused ...rezol(TM) (difluprednate ophthalmic emulsion) 0.05...s approved by the U.S. Food and,Drug Administratio...roid,indicated for the treatment of inflammation a...
(Date:10/6/2008)...nt of moderate to severe patients achieved endosco...oscopic remission at Week 10,in data from a 54-wee...ge,of Gastroenterology (ACG) Annual Scientific Mee...oday presented data from a,large, prospective stud...disease (CD) with a biologic compound. The data pr...
(Date:10/6/2008)...RNewswire-FirstCall/ -- Dendreon Corporation (Nasd...y, October 6, 2008 at 9:00 AM,ET (6:00 AM PT) to r...MPACT,(IMmunotherapy for Prostate AdenoCarcinoma T...PROVENGE(R) (sipuleucel-T), the Company,s investig...tment of advanced prostate,cancer., Those inte...
Breaking Medicine Technology:Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain 2Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain 3Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 2Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 3Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 4Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 5CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 2CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 3CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 4CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 5CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 6CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 7Dendreon to Hold a Conference Call Today at 9:00 AM ET to Provide an Update on Interim Results of Phase 3 PROVENGE IMPACT Trial 2The Integrated Benefits Institute Offers Largest Benchmarking Database in U S Spanning Disability and Workers Compensation Programs 1831 1The Integrated Benefits Institute Offers Largest Benchmarking Database in U S Spanning Disability and Workers Compensation Programs 1831 2Murad Boosts Skin Immunity With the New Murad 28R 29 Professional Line 791 1Murad Boosts Skin Immunity With the New Murad 28R 29 Professional Line 791 2OmniSonics Appoints J Daniel Cole Chairman of the Board 787 1OmniSonics Appoints J Daniel Cole Chairman of the Board 787 2Velcura Therapeutics Inc Reports Positive Pre IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disea 368 1Velcura Therapeutics Inc Reports Positive Pre IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disea 368 2Velcura Therapeutics Inc Reports Positive Pre IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disea 368 3
...ive Oncology Compounds at the,American Association...Ill., April 13, 2007 /PRNewswire-FirstCall/ -- For... that target,cancer. Researchers now know that can...hey require new blood vessels to deliver oxygen,an...ly,(proliferation), they travel throughout the bod...
...r 12, 2007 - CombinatoRx,Incorporated (NASDAQ: CR...ncology research efforts will be presented at the ...r Cancer Research,April 14-18, 2007 in Los Angele... Combinations for,Cancer Therapy", Heilbut, et.al....il 15, 1-5pm PT and "Synergistic Enhancers of,TRAI...
Other Medicine Technology:Abbott Researchers Focus on New Cutting-Edge Approaches in the,Fight Against Cancer 2Abbott Researchers Focus on New Cutting-Edge Approaches in the,Fight Against Cancer 3Abbott Researchers Focus on New Cutting-Edge Approaches in the,Fight Against Cancer 4CombinatoRx to Present Combination High Throughput Screening (cHTS),Data at Upcoming AACR Meeting 2CombinatoRx to Present Combination High Throughput Screening (cHTS),Data at Upcoming AACR Meeting 3